We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 85.25-0.3%Sep 29 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stockdoc77 who wrote (53386)12/8/2019 8:36:23 AM
From: scorman13 Recommendations

Recommended By

  Read Replies (1) of 58525
I believe it was either stockdoc or li who at one point made the comment that SG was not a cure but a treatment. I would like a more detailed perspective on the semantics, since with 6 CRs for a heavily treated population...I would think that is a cure? As a side note: we had an elderly neighbor who had lung cancer 20 years ago, had a lung removed, and in early 2000s had Avastin? and was clear for 15 years...I consider that a cure.

This weeks action looked like a short squeeze to me....takes large volume and sharp price rise.
For those who want daily naked short stats, here are two links:

daily short interest

naked short report

To be quite honest, this stock from back in late 90's has NOT be worth the pain!
The failure a year ago when 37/38 others got approved was mind boggling to me with all the high paid execs we brought on board

I had anticipated being able to pay my kids college tuition and they have long since graduated.
Yes I am + here and have good expectations over the next few months, and I have still not touched my core positions. More than likely I will sell 1/3 after New years and then sell 1/3 in the money calls going into the next year to spread the tax bite. Would not surprise me if we had a takeover at a 3x+ market cap from where we are now.

slightly OT qs- What does it take for SG to be approved as a first line mono treatment? How do we get around not giving the standard of care?

Stew Corman from sunny Endicott
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext